Teva Pharmaceuticals International GmbH v. Almaject Inc. - 1:25-cv-01168

Teva Pharmaceuticals International GmbH v. Almaject Inc. (Case No. 1:25-cv-01168), filed on Sep 18, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-01168
Filing Date
Sep 18, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Alvogen, Inc. -
Eagle Sub1 LLC -
Cephalon LLC -
Teva Pharmaceuticals International GmbH -
Almaject Inc. -

Patents Involved

This case involves 19 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 18, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than August 6, 2025. Date of Expiration of Patent: 8,609,707 expires 8/11/2031, 9,265,831 expires 1/28/2031, 9,572,796 expires 1/28/2031, 9,572,797 expires 1/28/2031, 9,034,908 expires 3/15/2033, 9,144,568 expires 3/15/2033, 9,572,887 expires 3/15/2033, 9,597,397 expires 3/15/2033, 9,597,398 expires 3/15/2033, 9,597,399 expires 3/15/2033, 9,000,021 expires 3/15/2033, 9,579,384 expires 3/15/2033, 10,010,533 expires 1/28/2031, 10,052,385 expires 3/15/2033, 11,844,783 expires 1/28/2031, 11,872,214 expires 1/28/2031, 12,138,248 expires 1/28/2031, 12,350,257 expires 1/28/2031, 12,343,333 expires 1/28/2031.Thirty Month Stay Deadline: 2/6/2028. (slk) (Entered: 09/19/2025)PACER Document
Sep 18, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (slk) (Entered: 09/19/2025)PACER Document
Sep 18, 2025COMPLAINT against Almaject Inc. & Alvogen, Inc. (Filing fee $ 405, receipt number ADEDC-4792848) - filed by Teva Pharmaceuticals International GmbH, Cephalon LLC, Eagle Pharmaceuticals, Inc., Eagle Sub1 LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Civil Cover Sheet)(slk) (Entered: 09/19/2025)PACER Document